Brief: China Health Group Says Unit Has Been Granted Exclusive Promotion Service License For "Olmitevirumab Injection" In Beijing
08/04/2022 16:06
April 8 (Reuters) - China Health Group Ltd 0673.HK :
* UNIT HAS BEEN GRANTED EXCLUSIVE PROMOTION SERVICE LICENSE
FOR
"OLMITEVIRUMAB INJECTION" IN BEIJING
Source text for Eikon: ID:nHKS9r4JKw
Further company coverage: 0673.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Health
See all newsChina's drug regulator accepts Novo Nordisk's application for oral Wegovy (updated)
Brief: China Health Group Files Civil Appeal On 3 June 2026 With Chengde Intermediate Court
Brief: China Health Group To Issue 48 Million Shares At Hk$0.53 Per Share
Brief: China Health Appoints Ying Rensi As Executive Director
Brief: China Health Announces Resumption Of Trading